Regionalize for resilience
Resilinc
SEPTEMBER 20, 2022
became more dependent on foreign manufacturers for active pharmaceutical ingredients (APIs). The Drug, Chemical & Associated Technologies Association have blamed this on a “race to the bottom” mentality that drove manufacturing to low-cost countries such as India and China, which are now the largest global suppliers of APIs.
Let's personalize your content